A comparative genomics analysis of lung adenocarcinoma for Chinese population by using panel of recurrent mutations

被引:0
|
作者
Wanlin Li [1 ]
Min Wu [1 ]
Qianqian Wang [2 ]
Kun Xu [2 ]
Fan Lin [3 ]
Qianghu Wang [1 ,4 ]
Renhua Guo [2 ]
机构
[1] Department of Bioinformatics,Nanjing Medical University
[2] Department of Oncology,the First Affiliated Hospital of Nanjing Medical University
[3] Department of Cell Biology,School of Basic Medical Sciences,Nanjing Medical University
[4] Jiangsu Key Lab of Cancer Biomarkers,Prevention and Treatment,Collaborative Innovation Center for Cancer Personalized Medicine
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
100214 ;
摘要
Previous studies have demonstrated that Chinese lung adenocarcinoma(LUAD) patients have unique genetic characteristics,however,the specific genomic features relating to the development and treatment of LUAD in the Chinese population are not fully understood.Here,we applied the ultra-deep targeted sequencing to 66 Chinese LUAD samples,accompanied by comparative analysis with 162 Caucasian LUAD in The Cancer Genome Atlas.We focused on the 68 recurrently mutated genes and results revealed that the panel-based tumor mutational burden(pTMB) is significantly higher in the Chinese LUAD(P=0.0017).Additionally,the percentage of smoking-associated C>A transversion is significantly lower in Chinese LUAD(15.5% vs.39.7%,P=5.69×10;),while C>T transition is more frequent in Chinese LUAD(35.8% vs.25.7%,P=2.67×10;),which indicated the ethnic difference in mutation types.Notably,novel driver genes(GNAS and JAK1) that are peculiar to Chinese LUAD were identified,and a more convergent distribution of mutations was observed in the Chinese cohort(P=0.012) compared with scattered mutations in Caucasian LUAD.Our results present a distinct genomic profile of Chinese LUAD compared to Caucasians LUAD and elucidate the ethnic difference in mutation distribution besides the type and rate.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 50 条
  • [1] A comparative genomics analysis of lung adenocarcinoma for Chinese population by using panel of recurrent mutations
    Li, Wanlin
    Wu, Min
    Wang, Qianqian
    Xu, Kun
    Lin, Fan
    Wang, Qianghu
    Guo, Renhua
    JOURNAL OF BIOMEDICAL RESEARCH, 2021, 35 (01): : 11 - 20
  • [2] CLINICAL CHARACTERISTICS AND PROGNOSIS OF LUNG ADENOCARCINOMA DRIVER MUTATIONS FROM CHINESE POPULATION
    Dong, Yu
    Li, Ying
    Jin, Bo
    Peng, Hong
    Xiong, Hui
    Han, Baohui
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S918 - S918
  • [3] A Microsatellite Instability Analysis Using the Promega Panel in Lung Adenocarcinoma
    Takamochi, Kazuya
    Takahashi, Fumiyuki
    Suehara, Yoshiyuki
    Kitano, Shigehisa
    Sato, Eiichi
    Kohsaka, Shinji
    Suzuki, Kenji
    CHEST, 2016, 150 (04) : 715A - 715A
  • [4] Efficacy and safety of afatinib in a Chinese population with advanced lung adenocarcinoma with sensitive EGFR mutations
    Wang, Shouzheng
    Xing, Puyuan
    Yang, Ke
    Hao, Xuezhi
    Ma, Di
    Mu, Yuxin
    Li, Junling
    THORACIC CANCER, 2019, 10 (06) : 1461 - 1468
  • [5] Early detection of lung cancer by using an autoantibody panel in Chinese population
    Ren, Shengxiang
    Zhang, Shucai
    Jiang, Tao
    He, Yayi
    Ma, Zhiyong
    Cai, Hourong
    Xu, Xiaohong
    Li, Yan
    Cai, Weijing
    Zhou, Jing
    Liu, Xiaopeng
    Hu, Xuejun
    Zhang, Jun
    Yu, Hui
    Zhou, Caicun
    Hirsch, Fred R.
    ONCOIMMUNOLOGY, 2018, 7 (02):
  • [6] Analysis of mutations in lung adenocarcinoma using the next generation sequencing
    Kulda, V.
    Polivka, J.
    Svaton, M.
    Vanecek, T.
    Vankova, B.
    Shetti, D.
    Houfkova, K.
    Buresova, M.
    Pesta, M.
    FEBS OPEN BIO, 2022, 12 : 102 - 103
  • [7] Introducing a panel for early detection of lung adenocarcinoma by using data integration of genomics, epigenomics, transcriptomics and proteomics
    Haghjoo, Niloofar
    Moeini, Ali
    Masoudi-Nejad, Ali
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 112
  • [8] Efficacy and Safety of Afatinib for Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutations in Chinese Population
    Wang, S.
    Xing, P.
    Yang, K.
    Hao, X.
    Ma, D.
    Mu, Y.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1039 - S1039
  • [9] Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis
    Peng, Zhuo
    Pan, Longfei
    Niu, Zequn
    Li, Wei
    Dang, Xiaoyan
    Wan, Lin
    Zhang, Rui
    Yang, Shuanying
    ONCOTARGET, 2017, 8 (38) : 64143 - 64156
  • [10] Genomic Mutations of Primary and Metastatic Lung Adenocarcinoma in Chinese Patients
    Chen, Xinyu
    Bu, Qing
    Yan, Xuexin
    Li, Ye
    Yu, Qian
    Zheng, Haiping
    Zhao, Liang
    Zeng, Yanwu
    Lu, Leilei
    Lan, Dong
    Ma, Jie
    JOURNAL OF ONCOLOGY, 2020, 2020